Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Hold" by Analysts

Retrieved on: 2021-02-25 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Hold" by Analysts. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 469,115 shares of the biotechnology company's stock worth $21,474,000 after acquiring an additional ...

Article found on: www.marketbeat.com